| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.086 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |